DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)

company name or ticker

3 Stocks Crushed by the Market This Week

Find out which health-care stocks got beaten down the most by the market over the past few days.

Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3% - Tale of the Tape

Why Antares Pharma Inc. Shares Dove

Antares shares go off track following the resignation of its CEO. Find out if this is something investors should be genuinely concerned about or if it's a short-term event.

Otrexup Sales Trajectory Points To First Profitable Quarter For Antares Pharma In 2015

Is Antares Pharma A Short-Squeeze Candidate?

Antares Pharma's (ATRS) CEO Paul Wotton on Q1 2014 Results - Earnings Call Transcript

Antares Pharma Announces Additional Patent Coverage for OTREXUP

Stocks Hitting 52-Week Lows

Antares Pharma Inc. Stock Downgraded (ATRS)

Antares Pharma: Recent Sell-Off Provides Great Entry Point

See More Articles...